LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway

Hailin Tang1, Zeyou Wang, Xiaoping Liu

  • 1Cancer Research Institute, Central South University, Changsha, Hunan, China.

Insights

Leucine-rich repeat C4 (LRRC4) suppresses glioma by regulating miR-185. Lower levels of LRRC4 and miR-185 correlate with poor glioma patient outcomes, suggesting their potential as prognostic markers.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genetics

Background:

  • Leucine-rich repeat (LRR) genes are crucial for brain development and implicated in central nervous system tumors.
  • Leucine-rich repeat C4 (LRRC4) is a brain-specific LRR protein functioning as a tumor suppressor in malignant gliomas.
  • The precise molecular mechanisms of LRRC4's tumor suppressor activity in glioma remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying LRRC4's tumor suppressor role in glioma.
  • To investigate the relationship between LRRC4, miR-185, and glioma cell invasion.
  • To evaluate LRRC4 and miR-185 as potential prognostic markers for glioma patients.

Main Methods:

  • Analysis of LRRC4-mediated upregulation of miR-185.
  • Assessment of miR-185 expression levels in glioma tissues.
  • Evaluation of the impact of miR-185 overexpression on glioma cell invasion.
  • Correlation analysis of LRRC4 and miR-185 expression with patient outcomes.
  • Investigation of LRRC4's regulation of miR-185 targets (CDC42, RhoA) and VEGFA.

Main Results:

  • LRRC4 significantly upregulates miR-185 expression.
  • miR-185 is downregulated in glioma, and its overexpression inhibits glioma cell invasion.
  • Low expression of both LRRC4 and miR-185 is associated with poor prognosis in glioma patients.
  • LRRC4 exerts its tumor suppressor function by regulating miR-185 targets CDC42 and RhoA, and indirectly affecting VEGFA.

Conclusions:

  • Altered LRRC4 expression contributes to miR-185 dysregulation in human gliomas.
  • The LRRC4/miR-185 pathway plays a critical role in glioma tumorigenesis.
  • LRRC4 and miR-185 show promise as prognostic biomarkers and therapeutic targets for glioma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...